<DOC>
	<DOCNO>NCT00491504</DOCNO>
	<brief_summary>The purpose study evaluate well mometasone furoate nasal spray ( MFNS ) work relieve SAR symptom compare Placebo symptom induce chamber setting . Evaluation base subject self-assessed nose symptom . Other area study evaluate : 1 ) change eye symptom ( ocular symptom severity score ) dose 2 ) long MFNS work relieve nose ( nasal ) eye ( ocular ) symptom 7 daily dos , 3 ) measurement nose ( nasal ) blockage ( obstruction ) , 4 ) measurement subject 's opinion study drug ask different question . This study could last 53 day subject .</brief_summary>
	<brief_title>This Study Contains Active Drug Treatment Group With Mometasone Furoate Nasal Spray Placebo ( Dummy ) Treatment Group Seasonal Allergic Rhinitis ( SAR ) . ( Study P05073 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>Willing participate adhere dose visit schedule 18 65 year , either sex , race 2year history SAR , symptomatic last 2 ragweed season Skin test positive short ragweed allergen screening , positive within 12 month Women must practice adequate contraception : Females childbearing potential ( include woman less 1 year postmenopausal woman sexually active study ) must agree use medically accept method contraception surgically sterilize prior screen , receive protocolspecified medication , 30 day stop medication . Women postmenopausal &gt; 1 year ( ie , woman experience 12 consecutive month amenorrhea ) exempt use contraception study . ; Acceptable method contraception include condom ( male female ) without spermicidal agent , diaphragm cervical cap spermicidal agent , medically prescribe intrauterine device ( IUD ) , oral injectable hormonal contraceptive , surgical sterilization ( eg , hysterectomy tubal ligation ) Negative pregnancy test study Compromised ability provide inform consent Nasal abnormality , include large nasal polyp , mark septum deviation interferes nasal airflow screen Recent ( within last 2 week ) unhealed nasal septum ulcer , nasal surgery , nasal trauma Unstable asthma control inhaled shortacting beta2 agonist Diagnosed sinusitis within previous 2 week Is initiate currently advance immunotherapy If immunotherapy ( desensitization therapy ) , subject must stable receive increase dose study . Subjects may receive desensitization treatment within 24 hour prior study visit Is currently antihistamine , decongestant ( topical systemic ) nasal inhale corticosteroid 14 day prior first prim visit Unable refrain regular use nasal , oral ocular decongestant , nasal topical antihistamine , nasal steroid Failed designate washout period prohibit medication Upper low respiratory tract sinus infection require antibiotic therapy viral upper low respiratory infection within 14 day prior screen Is allergic sensitivity study drug excipients Used investigational product within 30 day enrollment antibody asthma allergic rhinitis past 90 day Subject Chronic obstructive pulmonary disease , Alcohol abuse , Rhinitis medicamentosa</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>